Normal Human Peripheral Blood Natural Killer Cells(CD56+)

Normal Human Peripheral Blood Natural Killer Cells (CD56+) are primary innate lymphocytes obtained from the peripheral blood of healthy donors. They participate in immune surveillance by recognizing and eliminating susceptible tumor cells and virus-infected cells without prior antigen-specific sensitization. NK-cell activity reflects the integration of activating and inhibitory receptor signals, enabling investigation of how immune recognition translates into target-cell killing.

CD56+ peripheral blood NK populations comprise functionally diverse subsets. CD56dim cells predominate and commonly express CD16, whereas CD56bright cells generally express lower or undetectable CD16. Both subsets can produce interferon-γ following appropriate stimulation, and their responses depend on the activating signals received. This diversity supports complementary studies of cytotoxicity, cytokine production, receptor signaling, and cellular activation rather than a single effector endpoint.

A principal advantage is their combination of direct cytotoxicity and antibody-dependent effector function. CD16-expressing NK cells can recognize the Fc region of target-bound IgG and mediate antibody-dependent cellular cytotoxicity (ADCC). This makes peripheral blood NK cells particularly valuable for evaluating therapeutic antibodies, Fc-dependent mechanisms, and strategies that enhance antitumor responses.

These cells offer versatile readouts, including target-cell killing, CD107a degranulation, cytokine secretion, and immunophenotypic changes. Healthy-donor preparations provide a reference for comparisons with disease-associated NK-cell populations and for assessing candidate immunomodulators.